GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhuzhou Qianjin Pharmaceutical Co Ltd (SHSE:600479) » Definitions » Net Income (Discontinued Operations)

Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) Net Income (Discontinued Operations) : ¥0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Zhuzhou Qianjin Pharmaceutical Co Net Income (Discontinued Operations)?

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods. Zhuzhou Qianjin Pharmaceutical Co's Net Income (Discontinued Operations) for the three months ended in Mar. 2025 was ¥0 Mil. Its Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0 Mil.


Zhuzhou Qianjin Pharmaceutical Co Net Income (Discontinued Operations) Historical Data

The historical data trend for Zhuzhou Qianjin Pharmaceutical Co's Net Income (Discontinued Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhuzhou Qianjin Pharmaceutical Co Net Income (Discontinued Operations) Chart

Zhuzhou Qianjin Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income (Discontinued Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Zhuzhou Qianjin Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income (Discontinued Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Zhuzhou Qianjin Pharmaceutical Co Net Income (Discontinued Operations) Calculation

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods.

Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhuzhou Qianjin Pharmaceutical Co Net Income (Discontinued Operations) Related Terms

Thank you for viewing the detailed overview of Zhuzhou Qianjin Pharmaceutical Co's Net Income (Discontinued Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhuzhou Qianjin Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 801, Zhuzhou Avenue, Tianyuan District, Hunan Province, Zhuzhou, CHN, 412000
Zhuzhou Qianjin Pharmaceutical Co Ltd is engaged in Chinese medicine, chemical medicine, and health supplies businesses in China. It produces medicines in the form of tablets, granules, and hard capsules. The company's products include Gynecological Qianjin Tablets (Capsules), Blood-Boosting Yimu Pills (Granules), Valsartan Capsules, Enalapril Maleate Tablets, Difenidol Hydrochloride Tablets, Silybin Meglumine Tablets, Entecavir Dispersible Tablets, Gynecological Special Cotton Towel Series, etc.
Executives
Liu Jian Wu senior management
Li Fu Jun Director
Lv Fang Yuan Supervisors
Zhang Shun Li Supervisors
Chen Geng senior management
Zhu Fei Jin Director

Zhuzhou Qianjin Pharmaceutical Co Headlines

No Headlines